Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
1.570
+0.210 (15.44%)
At close: Dec 20, 2024, 4:00 PM
1.560
-0.010 (-0.64%)
After-hours: Dec 20, 2024, 7:54 PM EST
Biodesix Market Cap
Biodesix has a market cap or net worth of $228.38 million as of December 20, 2024. Its market cap has increased by 58.76% in one year.
Market Cap
228.38M
Enterprise Value
259.48M
1-Year Change
58.76%
Ranking
Category
Stock Price
$1.57
Market Cap Chart
Since the IPO on October 28, 2020, Biodesix's market cap has decreased from $472.57M to $228.38M, a decrease of -51.67%. That is a compound annual growth rate of -16.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 228.38M | 37.19% |
| Dec 29, 2023 | 166.48M | -5.38% |
| Dec 30, 2022 | 175.94M | 23.06% |
| Dec 31, 2021 | 142.97M | -73.28% |
| Dec 31, 2020 | 535.07M | 13.23% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lexeo Therapeutics | 199.72M |
| Atai Life Sciences | 199.68M |
| MacroGenics | 199.59M |
| Akso Health Group | 198.11M |
| Inogen | 197.93M |
| Verastem | 197.61M |
| XBiotech | 193.27M |
| Perspective Therapeutics | 191.95M |